| Entry |
|
|---|
| Name |
Sparfloxacin;
cis-5-Amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
|
|---|
| Formula |
C19H22F2N4O3
|
|---|
| Exact mass |
392.166
|
|---|
| Mol weight |
392.3998
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Pathway |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01M QUINOLONE ANTIBACTERIALS
J01MA Fluoroquinolones
J01MA09 Sparfloxacin
D00590 Sparfloxacin (JAN/USAN/INN)
Drug groups [BR:br08330]
Antibacterial
DG01550 Quinolone
DG01549 Fluoroquinolone
D00590 Sparfloxacin
Antimicrobials [BR:br08307]
Antibacterials
Nucleic acid synthesis inhibitor
Fluoroquinolone
D00590 Sparfloxacin (JAN/USAN/INN)
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Nucleic acid synthesis inhibitor
Fluoroquinolone
D00590 Sparfloxacin (JAN/USAN/INN)
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 28
1 C8y C 26.0745 -16.6053
2 C8y C 26.0745 -15.2064
3 N4y N 27.2868 -17.3048
4 C8y C 24.8620 -17.3048
5 C8y C 27.2402 -14.5069
6 C8y C 24.8620 -14.5069
7 C1y C 27.2868 -18.7037
8 C8x C 28.4992 -16.5587
9 C8y C 23.6496 -16.6053
10 X F 24.8620 -18.7037
11 C8y C 28.4992 -15.1598
12 O5x O 27.2402 -13.1080
13 C8y C 23.6496 -15.2064
14 N1a N 24.8620 -13.1080
15 C1x C 27.9863 -19.9162
16 C1x C 26.5407 -19.8695
17 C6a C 29.6650 -14.4603
18 X F 22.4372 -14.5069
19 O6a O 30.8774 -15.2064
20 O6a O 29.6650 -13.0614
21 N1y N 22.4372 -17.3048
22 C1x C 21.2248 -16.6053
23 C1y C 20.0124 -17.3048
24 N1x N 20.0124 -18.7037
25 C1y C 21.2248 -19.4032
26 C1x C 22.4372 -18.7037
27 C1a C 21.2714 -20.8021
28 C1a C 18.8000 -16.6053
BOND 31
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 1
7 3 8 1
8 4 9 2
9 4 10 1
10 5 11 1
11 5 12 2
12 6 13 2
13 6 14 1
14 7 15 1
15 7 16 1
16 11 17 1
17 13 18 1
18 17 19 1
19 17 20 2
20 8 11 2
21 9 13 1
22 15 16 1
23 9 21 1
24 21 22 1
25 22 23 1
26 23 24 1
27 24 25 1
28 25 26 1
29 21 26 1
30 25 27 1 #Up
31 23 28 1 #Up
|
|---|
